RecruitingPostoperative BleedingSkin Cancer Face
Tranexamic Acid in Nasal Mohs Reconstruction
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study will be a prospective randomized control trial to evaluate the effects of subcutaneously administered TXA among patients undergoing nasal Mohs reconstruction with local flaps at VUMC.
Sponsor: Vanderbilt University Medical Center
You may qualify if…
- ✓ 1. Adults at least 18 years of age undergoing local flap reconstruction (bilobe flap, note flap dorsal nasal flap, advancement flap) of a nasal defect following Mohs micrographic surgery. Reconstructive procedures will be performed by Drs. Yang or Patel in the division of Facial Plastic Surgery in the Department of Otolaryngology, Head and Neck Surgery at Vanderbilt University Medical Center.
- ✓ 2. No other facial plastic procedure or sinus surgery performed simultaneously.
- ✓ 3. Lack of all the below exclusion criteria.
You may not qualify if…
- ✕ 1. Known allergy to TXA
- ✕ 2. Intracranial bleeding
- ✕ 3. Known defective color vision
- ✕ 4. History of venous or arterial thromboembolism
- ✕ 5. History of coagulation disorder
- ✕ 6. Active thromboembolic disease
- ✕ 7. Severe renal impairment (diagnosis of chronic kidney disease)
- ✕ 8. History of acute myocardial infarction
Where it's recruiting
Tennessee
Nashville
Source: ClinicalTrials.gov · NCT06057675 · last updated 2025-08-19